PanGenomic Health Inc. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. PANGENOMIC HEALTH A AKTIE Termine - hier erhalten Sie eine Übersicht über alle anstehenden und vergangenen Termine wie Quartalszahlen und Hauptversammlung von PANGENOMIC HEALTH A AKTIE. Nara App also Supports New FTC Regulatory Guideline for Science-Backed Information about Natural Remedy. nasdaq 100. PanGenomic Health Inc. Risikoanalyse zu PANGENOMIC HEALTH A anhand von objektiven Faktoren wie z. (dba Bello Capital Partners) 310 Water Street, Suite 306. Public Health Association of BC: PHABC, Victoria, BC. 12 April 2023 at 2:00 am · 8-min read. CD. %. PanGenomic Health Inc. For more information, please contact: Jerry Lai, Investor Relations Maryam Marissen, President & CEO. 0000. 00; Net income in CAD-12. . Name. CSE) on Friday announced the soft launch of thePanGenomic offers a self-care digital platform to deliver personalized, evidence-based information about natural and plant-based health treatments, according to the company. Pangenomic Health Inc. *Close price adjusted for splits. Pangenomic Health A Realtimekurs. 778 743 4642. PanGenomic Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 May. 12 April 2023 at 2:00 am · 8-min read. CA24463V1013. CSE: NARA, is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the “Transaction”) of Mindleap Health Inc. The company has a very good potential for expansion. The Company's initial. 778 743 4642 778 743 4642. PANGENOMIC HEALTH A Chart - ein übersichtlicher, großer Chart der PANGENOMIC HEALTH A Aktie. PanGenomic Health Inc. Aktie. Rückschlagspotentiale, Bad News Faktor, Beta und Korrelation The Company also announced that its board of directors has approved a reduction of the exercise price of an aggregate of outstanding 45,472,751 share purchase warrants of the Company (the. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics. (the “Issuer”). kündigt. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 17 Following. Artikel lesen 02. EPS -0. 1R_ZMeS5ZPiASkYU_9b0lh7oCXsL-ysm26Zf4xxK1a3pDMoWx55x_7BzXA Advanced. euro stoxx 50. PanGenomic Health Admitted to Trading on the AQSE Growth Market in London,. 1,08M. Company Profile. PANGENOMIC HEALTH share price in real-time (A3DN26 / CA69842E2050), charts and analyses, news, key data, turnovers, company data. View funds that move the market, screen for funds and read relevant news. Alle DAX Werte in Realtime, Echtzeitkurse und im Push Format. PanGenomic Health Inc. 778 743 4642 info@pangenomic. ADRs) Westag & Getalit AG (Vz. New look and feel! Ratings and Reviews 5. Ausländisches Symbol. PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement PR Newswire LONDON, United Kingdom, November 02 2 November 2023 PanGenomic Health. 01. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Together, we are working on a family of products that address significant gaps in healthcare, spanning mental health support, conventional treatment. “PanGenomic Health acknowledges the benefits that many pharmaceutical drugs provide to individuals suffering from mental health conditions, but there is growing consumer demand for natural alternatives and increasing scientific uncertainty about the effectiveness of many pharmaceutical drugs, such as anti-depressant drugs”, said. 13 April 2023 - 08:57. ADRs) Liste der 50 Auslands-Aktien über einem Euro mit höchster Tagesperformance über alle Segmente. President & CEO. 778 743 4642 778 743 4642. Equities NARA CA69842E2050 Advanced Medical Equipment & Technology Delayed Canadian Securities Exchange. PanGenomic Health PBC | 211 followers on LinkedIn. VANCOUVER, BC, Nov. PanGenomic Health Inc. . 58,940. VANCOUVER, BC, Jan. 12 April 2022. [email protected] valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. The LOI contemplates that the Pangenomic will acquire all of Mindleap's outstanding shares for a purchase price of. 08. helloitsasos , 11/18/2022. VANCOUVER, BC, Jan. Popular Searches. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. The Company's initial. CI Pangenomic Health Inc. Take a look at our analysis of LL30’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately. EUR. Push Kurse werden börsentäglich von 8:00 bis 23:00 Uhr, samstags von 10:00 bis 13:00 Uhr und sonntags von 17:00 bis 19:00 Uhr aktualisiert. Top 50 Performer Ausland. PanGenomic Health Inc. Pangenomic Health Inc. Letzte Dividende. S&P 500. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. PanGenomic Health Inc. -4,11 %. +/-%. ISIN. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG. (A) (spons. The patent-pending LivNao IP includes technology which combines smartphone sensor data and. Investor Help Forum;06 Sep, 2022, 19:17 ET. PanGenomic Health, Inc. PanGenomic is also pleased to announce that the escrow release conditions for its recently completed financing of 7,365,999 subscription receipts (the "Subscription Receipts") at a price of $0. 13: Sales - Tangible Book Value 0. operates as a health care platform company. . EVAHF. Pangenomic Health Inc. ir@pangenomic. Anzeige. At the core of our evidence-based health platform is an. By continuing to use our service, you agree to our use of cookies. (formerly named PlantGx Diagnostics Corp. PanGenomic Health. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. Official Data Partner. 604 417 4440. Die Nutzung der comdirect-Website ist ohne JavaScript nicht möglich. 9, 2023 /CNW/ - PanGenomic Health Inc. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health and wellness. The Health Professions Review Board (HPRB) is an administrative tribunal created under the Health Professions Act (the Act). Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. The. com. PanGenomic Health, Inc. , has signed an agreement to lease space at Psy Integrated Health. Die Pangenomic Health A-Aktie stieg im Frankfurt-Handel. Log in to view data. PanGenomic Health Profile and History . 1 M. November 21, 2022 at 12:07 p. Offtake Partner – Refractories for Steel Industry. VANCOUVER, BC. Own your health journey . This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic Health and the consideration to be paid to PanGenomic Health. com. ("Hemex Health"), a Portland, Oregon-based medical diagnostic device company focused on developing life. Primary Industries. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement. Mindleap-App von PanGenomic Health wird zur All-in-One-App und Telemedizin-Plattform für ganzheitliche psychische Gesundheit und Resilienz ausgebautPangenomic Health Inc. euro stoxx 50. Discover historical prices for NARA. About PanGenomic Health Inc. 500€). Automatisch Scrollen. PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc. 0212 set on Aug 22, 2023. marktüblicher Spreads)! Oskar ist der einfache und intelligente ETF-Sparplan. Fobi AI (FOBI) announced the commercial launch of its wholly-owned subsidiary, PulseIR, with the signing of its first customer, PanGenomic Health Inc. Portfolio Tracking Watchlists Märkte Dividendenkalender Neu Community Blog Registrieren Anmelden Aktie. Nara is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness. 30: CI Pangenomic Health Inc. A3DN26. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. . Loading more data. For further information: Jerry Lai, Investor Relations, PanGenomic Health Inc, 778 743 4642, ir@pangenomic. euro stoxx 50. ("Mindleap") from Mydecine Innovations Group. announced that, further to the announcement made on January 9, 2023, the Company has launched its new visual identity, website and e-commerce store for its NARA brand, available at nara. PanGenomic Health Inc. Revenue. care will market its proprietary natural herbal remedy information. Pangenomic Health A Dividenden Chart in CAD Aktien handeln zu Top-Konditionen Aktien, ETFs, Derivate, Kryptos und mehr - jetzt für 0 Euro pro Trade handeln (zzgl. Realtime Aktienkurs der PanGenomic Health Aktie mit Live-Chart inkl. | 870747 | MSFT. 22, 2022 /CNW/ - PanGenomic Health Inc. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that it has initiated a non-brokered private placement financing of. has signed an letter of intent (LOI) for the sale of its digital technology subsidiary, Mindleap Health Inc. , 778 743 4642, info@pangenomic. LL30 | Complete PanGenomic Health Inc. Weltweit vertrauen Kunden der DWS als Anbieter für integrierte Anlagelösungen. Aktienverlauf & Wertentwicklung. Stocks. ("PanGenomic" or the "Company") (CSE: NARA), is pleased to announce, further to its news releases dated September 1, 2022 and November 21, 2022, the completion of its previously announced acquisition (the "Transaction") of Mindleap Health Inc. Ich möchte hier die Diskussion zur Aktie PanGenomic Health Solutions | PanGenomic eröffnen, um einen regen Austausch über die sich ergebenden Chancen. 2. com Patrick Callas, ND. The Company's initial focus is to support mental health. - November 22, 2023) - Investorideas. To view PanGenomic Health’s complete subsidiaries history, request access ». 11. NARA | Complete PanGenomic Health Inc. Kurs. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission. to Pangenomic Health Inc. Er kritisiert die Aktie als klinisch tot und verwirft Vorwürfe gegen den CEO, der seine Scheine laufen lässt. PanGenomic Health Inc. Dear Shareholders, As we. Es ist meine erste. Anzeige. PanGenomic Health Inc. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support. PanGenomic offers a self-care digital platform to deliver information about natural and plant-based health treatments. Medicinal herbs based solutions for various conditions and a. PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 12, 2023 /CNW/ - PanGenomic Health Inc. Pangenomic Health A Alternativen. See the latest PanGenomic Health Inc stock price (XCNQ:NARA), related news, valuation, dividends and more to help you make your investing decisions. Nov. PanGenomic Health Inc. . PanGenomic's. ("PanGenomic" or the "Company") (CSE: NARA) is pleased to announce that Bello Capital Partners ("Bello") has been retained to provide capital markets advisory and digital marketing services (the "Services"). have been approved for listing on the CSE. The firm's products includ Nara App and PlantGx Platform. 12 April 2023 at 2:00 am · 8-min read. As a public benefit company, Pangenomic is dedicated to helping improve individual health outcomes with smart-tech tools that leverage both nature and science — while maintaining a commitment to safety, efficacy, and ease of access. 2 days ago · Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. /NOT FOR DISTRIBUTION TO U. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. View the latest PanGenomic Health Inc. Ein Nutzer diskutiert die Aktie von Pangenomic Health Inc. (TSMC) (Spons. Aktuelle Aktienkurse der PANGENOMIC HEALTH INC, Börsenkurs. S. 0191. This was a Post-IPO Equity round raised on Dec 23, 2022. thyssenkrupp Materials Trading GmbH, an international raw materials trading and services company headquartered in Essen, Germany, entered into a long-term partnership and 10-year offtake agreement for the annual purchase of up to 35,000 tonnes of SuperFlake® graphite from the Molo Mine. Share your opinion and gain insight from other stock traders and investors. (LL30. Operating Status Active. nasdaq 100. 778 743 4642 [email protected], BC, Aug. Push Kurse werden börsentäglich von 8:00 bis 23:00 Uhr, samstags von 10:00 bis 13:00 Uhr und sonntags von 17:00 bis 19:00 Uhr aktualisiert. PanGenomic. Pangenomic Health Inc. This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic and the. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to. 9, 2023 /CNW/ - PanGenomic Health Inc. F) stock quote, history, news and other vital information to help you with your stock trading and investing. PanGenomic Health Inc. 74%. According to the National Institute of Mental Health Disorders, an estimated 26% of adults ages 18 and older suffer from a diagnosable mental disorder in a given year. is a wholly-owned subsidiary of PanGenomic Health Inc. PanGenomic Health is UK's first listed Public Benefit Corp after Aquis IPO. 1 Mydecine news release. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that it plans to launch its e-commerce platform for personalized natural health solutions this month. 21, 2022 /CNW/ - PanGenomic Health Inc. Find the latest Pangenomic Health Inc. : Kurs, Charts, Kurse, Empfehlungen, Fundamentaldaten, Echtzeitnews und Analysen Aktie Pangenomic Health Inc. “We are excited about. Name. VANCOUVER, BC, Sept. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. com. PanGenomic Health Announces Availability of Women's Hormonal Health DNA Report. KELLOGG AKTIE und aktueller Aktienkurs. Our initial focus. S. We believe that mental health and physical wellbeing should not be a luxury, but a basic human. VANCOUVER, BC, Jan. Potential. (PAN) auf einem Forum, das sich mit der Entwicklung von Impfstoffen und Therapien für Krebs befasst. Get the latest Pangenomic Health Inc (NARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by. Vancouver, British Columbia, Canada, May 30, 2023 – PanGenomic Health Inc. View real. PanGenomic Health Inc. PanGenomic Health Inc. VANCOUVER, BC, Jan. CA69842E2050. High growth companies in the Healthcare. PanGenomic Health Inc. No data available. Kurs. /CNW/ - PanGenomic Health Inc. EUR. , a Santa Clara-based medical device. 31, 2023 /CNW/ - PanGenomic Health Inc. stock news by MarketWatch. com folgen. PanGenomic will launch the PlantGx platform in Canada and the United States in the summer 2022. Compiled here, all relevant comments and discussions regarding the NARA Stock. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. About PanGenomic Health. Historical performance for Pangenomic Health Inc. All markets data located on FT. PanGenomic Health Inc. Information on stock, financials, earnings, subsidiaries, investors, and. The Company's initial focus is to support mental health. Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social. caPanGenomic Health Inc. PanGenomic Health Inc. 778 743 4642 info@pangenomic. The Company's initial focus is to support mental health. Basic loss per share from continuing operations was CAD 0. stock was issued. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth. Zuletzt verteuerte sich das. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. VANCOUVER, BC, Jan. VANCOUVER, BC, Nov. ca VANCOUVER, BC, March 28, 2023 /CNW/ - PanGenomic Health Inc. Pangenomic Health-Aktie (NARA) Forum: Teilen Sie hier Ihre Meinungen und Trading-Ideen. 1,05 USD. 38m; Incorporated 2015; Employees--Location Pangenomic Health Inc 102 3800 Wesbrook Mall VANCOUVER V6S 2L9 Canada CAN;. PanGenomic Health Inc. Founded Date 2015. com This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by. 00: Operating Profit-0. 00:TradingView ist eine Plattform für Trader und Investoren, die leistungsstarke Tools zur Marktanalyse bietet. VANCOUVER, BC, March 2, 2023 /CNW/ - PanGenomic Health Inc. Discover historical prices for NARA. PanGenomic Health Inc. PanGenomic Health Inc. mit einem hohe Streubesitz von 87%. ("PlantGx"), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. (LL30. 15. David Joshua Bartch is an entrepreneur and businessperson who founded Doctors Orders LLC, Audiotranscriptionist Com and Revolutionary Software LLC and who has been at the helm of 7 different companies. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalised, evidence-based information about natural treatments. Artikel lesen 01. WKN. (2022-12-22 | CSE:NARA) PanGenomic Health Issues Letter to Shareholders (2022-12-22 | CSE:NARA) PanGenomic Health Issues Letter to Shareholders. Letzter Kurs 08:56:21 Tradegate. (LL30. 1 Year Return –81. Pangenomic Health Inc. 000 Aktien. | CA69842E2050. 64% above the 52 week low of 0. Pangenomic Health Inc. David Coffman / George Duxberry. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Registered as a British Columbia benefit company, PanGenomic Health’s mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual. PANGENOMIC HEALTH INC. Company Profile. Den Basisprospekt und die Endgültigen Bedingungen erhalten Sie hier, die Basisinformationsblätter hier. Pangenomic Health Inc (LL30:MUN) set a new 52-week low during Thursday's trading session when it reached 0. (“PanGenomic” or the “Company”) (CSE: NARA), is pleased to announce that it has initiated a non-brokered private placement financing of up to 3,333,333 units (each a. PanGenomic Health Inc. operates as a precision health company. VANCOUVER, BC, Jan. has been appointed as the Company's AQSE Corporate Adviser. 0. PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement. As well, Fobi reported that it has granted, pursuant to its Stock Option Plan, a total of 3,814,892 stock options to several company employees and officers to purchase. is a precision health company. (formerly named PlantGx Diagnostics Corp. Mydecine to sell Mindleap to Pangenomic for $4M via LOI 2022-09-02 - Mr. VANCOUVER, BC, Nov. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Inc. VANCOUVER, BC, June 6, 2023 /CNW/ - PanGenomic Health Inc. As we close out our first year as a publicly-traded company, your team at PanGenomic Health is busy laying the groundwork for success in the burgeoning health technology industry. 0. PanGenomic Health Inc - PanGenomic Health Provides Update for NARA Product and Conversational AI PR Newswire LONDON, United Kingdom, June 06 6 June 2023 PanGenomic Health VANCOUVER, BC, Jan. +0,45 %. PANGENOMIC HEALTH A Schätzungen: Hier finden Sie einen Überblick über die erwartete Entwicklung der wichtigsten Kennzahlen. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. A copy of PanGenomic Health's financial statements for the year ended December 31, 2022 and the related Management's Discussion and Analysis is available on under PanGenomic Health's profile on. 12, 2023 /CNW/ - PanGenomic Health Inc. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Find the latest Pangenomic Health Inc. 13 PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. Key statistics. 31, 2023 /CNW/ - PanGenomic Health Inc. 616M. Bartch occupies the. company and executive profile by Barron's. 0500. news services or for dissemination in the United States Vancouver, British Columbia, December 23, 2022 – PanGenomic Health Inc. Pangenomic Health Inc (LL30:BER) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Es liegen keine Schätzungen zu dieser Aktie vor. , a Santa Clara-based medical device company ("LumiQuick "). The PanGenomic personalized health platform helps consumers and healthcare practitioners connect with precision plant-based mental health treatments. 6M, payable by the issuance of units of PanGenomic at a price of C$0. PanGenomic is committed to helping more people discover plant-based health remedies and giving them greater personal control over mental health treatments. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that it plans to launch its e-commerce platform for personalized natural health solutions this month. EGF THERAMED HEALTH AKTIE und aktueller Aktienkurs. 0,0224. A3DN26. (" PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission to trading on the Aquis Stock Exchange Growth Market ("AQSE") in the UK. est une entreprise de santé de précision qui a développé une plateforme numérique d'auto-soins pour fournir des informations personnalisées et fondées sur des preuves sur les traitements naturels. PanGenomic Health Inc. operates as a precision health company. Zeit. stock was issued. 17, 2023 /CNW/ - PanGenomic Health Inc. CA24463V1013. Chance: Fundamentalanalyse Risikoanalyse Alternativen. Free real-time prices, and the most active stock market forums in the UK. (“Meus”) to provide capital markets advisory, investor relations and corporate strategy services. 30: AN Pangenomic Health Inc. PanGenomic is a health-tech company with an AI platform that supports consumer applications offering Telehealth, and diagnostic tools designed to improve quality and accessibility of care for. (NARA-CN). (“PanGenomic Health” or the “Company”) (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. See other industries within the Information sector: All Other Telecommunications , Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services , Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers , Motion Picture and Video Industries , Newspaper, Periodical, Book,. PanGenomic Health Subsidiary Signs Non-Binding MoU with Psy Integrated Health for Diagnostic Testing Joint Venture. VANCOUVER, BC, Nov. It provides independent reviews of certain decisions. operates as a health care platform company. 5. -0,87%. 23, 2022 /CNW/ - PanGenomic Health Inc.